0001256484-24-000009.txt : 20240213
0001256484-24-000009.hdr.sgml : 20240213
20240213182349
ACCESSION NUMBER: 0001256484-24-000009
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: KEWAUNEE SCIENTIFIC CORP /DE/
CENTRAL INDEX KEY: 0000055529
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY APPARATUS & FURNITURE [3821]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 380715562
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-11877
FILM NUMBER: 24630747
BUSINESS ADDRESS:
STREET 1: 2700 W FRONT ST
CITY: STATESVILLE
STATE: NC
ZIP: 28677
BUSINESS PHONE: 7048737202
MAIL ADDRESS:
STREET 1: P O BOX 1842
CITY: STATESVILLE
STATE: NC
ZIP: 28687-1842
FORMER COMPANY:
FORMER CONFORMED NAME: KEWAUNEE SCIENTIFIC EQUIPMENT CORP /DE/
DATE OF NAME CHANGE: 19861216
FORMER COMPANY:
FORMER CONFORMED NAME: KEWAUNEE MANUFACTURING CO
DATE OF NAME CHANGE: 19680108
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NORTHERN TRUST CORP
CENTRAL INDEX KEY: 0000073124
STANDARD INDUSTRIAL CLASSIFICATION: STATE COMMERCIAL BANKS [6022]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 362723087
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 50 S LASALLE ST
CITY: CHICAGO
STATE: IL
ZIP: 60603
BUSINESS PHONE: 3126306000
MAIL ADDRESS:
STREET 1: 50 S LASALLE ST
CITY: CHICAGO
STATE: IL
ZIP: 60603
FORMER COMPANY:
FORMER CONFORMED NAME: NORTRUST CORP
DATE OF NAME CHANGE: 19780525
SC 13G/A
1
Kewaunee-s13g-a6-2023-12.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 6)
Kewaunee Scientific Corporation
(Name of Issuer)
Common Stock, $2.50 par value per share
(Title of Class of Securities)
492854104
(CUSIP Number)
December 31, 2023
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule
pursuant to which this Schedule is filed:
X Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
------------------------------------------------------------------
CUSIP 492854104
Page 2 of 6 Pages
1
Names of Reporting Persons
S.S. or I.R.S. Identification No. of above person
Northern Trust Corporation 36-2723087
The Northern Trust Company 36-1561860
2
Check the appropriate box if a member of a group
Not Applicable (a) [ ]
(b) [ ]
3
S.E.C. use only
4
Citizenship or place of organization
Northern Trust Corporation - a Delaware corporation
Number of Shares Beneficially owned by Each Reporting Person with
5
Sole Voting Power
1,000
6
Shared Voting Power
300,767
7
Sole Dispositive Power
7,851
8
Shared Dispositive Power
293,211
9
Aggregate amount beneficially owned by each reporting person
301,767
10
Check box if the aggregate amount in Row (9) excludes certain shares.
11
Percent of class represented by amount in Row 9
10.4
12
Type of reporting person
Northern Trust Corporation HC
The Northern Trust Company BK
------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934
Check the following box if a fee is being paid with statement [ ].
1. (a) Kewaunee Scientific Corporation
(Name of Issuer)
(b) 2700 W Front St, Statesville, NC 28677
(Address of Issuer's Principal Executive Office)
2. (a) Northern Trust Corporation
(Name of Person Filing)
(b) 50 South LaSalle Street, Chicago, Illinois 60603
(Address of Person Filing)
(c) Delaware Corporation
(Citizenship)
(d) Common Stock, $2.50 par value per share
(Title of Class of Securities)
(e) 492854104
(CUSIP Number)
3. This statement is being filed by Northern Trust Corporation as a
Parent Holding Company in accordance with S240.13d-1(b) (1) (ii) (G).
4. (a) 301,767
(Amount Beneficially Owned)
(b) 10.4
(Percent of Class)
(c) Number of shares as to which such person has:
(i) 1,000
(Sole Power to Vote or to Direct the Vote)
(ii) 300,767
(Shared Power to Vote or to Direct the Vote)
(iii) 7,851
(Sole Power to Dispose or Direct Disposition)
(iv) 293,211
(Shared Power to Dispose or Direct Disposition)
5. If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
5 percent of the class of securities, check the following: [ ]
6. Statement regarding ownership of 5 percent or more on behalf of another
person:
The securities are beneficially owned by Northern Trust
Corporation and its subsidiaries, such as The Northern Trust Company,
in their various fiduciary capacities.
7. Parent Holding Company reporting on behalf of the following subsidiaries,
all of which are banks as defined in Section 3(a) (6) of the Act:
The Northern Trust Company
50 South LaSalle Street
Chicago, IL 60603
8. Identification and Classification of Members of the Group.
Not Applicable.
9. Notice of Dissolution of Group.
Not Applicable.
10. By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect
of changing or influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in any transaction
having such purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
NORTHERN TRUST CORPORATION
________________________________
By: Angelo Manioudakis
As its Executive Vice President
DATED: 02-07-2024
-----------------------------------------------------------------------------
EXHIBIT TO SCHEDULE 13G
FILED BY NORTHERN TRUST CORPORATION
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549-1004
Attention: Filing Desk, Stop 1-4
RE: Kewaunee Scientific Corporation
Pursuant to the requirement of 240.13d-1(k) (1) (iii), this exhibit shall
constitute our written agreement that the Schedule 13G to which this
exhibit is attached is filed on behalf of Northern Trust Corporation and of
its subsidiary(ies), as stated below, regarding our respective beneficial
ownership in the above-captioned equity security.
NORTHERN TRUST CORPORATION
_________________________________
By: Angelo Manioudakis
As its Executive Vice President
DATED: 02-07-2024
THE NORTHERN TRUST COMPANY
________________________________________
By: Angelo Manioudakis
As its Executive Vice President